东阳光_公司详情_供应商_CPHI制药在线专业网上贸易平台

制药在线首页

公司概况
成立年份： 2002
总资产(USD)：不愿意公开
员工总人数： 500以上
主要竞争优势：国际认证/标准，经验丰富的研发人员，生产能力，接受小额订单，良好的信誉
其他竞争优势：
专利与版权：

业务概况
业务类型：制造商，出口商
年销售额(USD)： 100,000,000至249,999,999
主要销售市场：北美洲，西欧，亚洲
主要产品类别：原料药，中间体

所有产品：

HEC’s Drug Substances (APIs) Catalog

API Name	Commercial availability	Standards	DMF/CEP/FDA
Atorvastatin calcium	Now	Ph.Eur and USP	CEP 2012-382
Levofloxacin	Now	USP and CP	DMF No.: 26295
Esomeprazole sodium	Now	In-house standard	DMF available
Esomeprazole magnesium	Now	Ph.Eur and USP	DMF available
Olanzapine	Now	Ph.Eur, USP and National Standard	CEP 2012-406 DMF 26763
Felodipine	Now	Ph.Eur, USP and CP	CEP 2013-023 DMF 26811
Entacapone	Now	Ph.Eur and USP	DMF available in 2013
Prasugrel hydrochloride	Now	In-house standard	DMF 26769
Bambuterol	Now	Ph.Eur and CP	NA
Azilsartan	Now	In-house standard	DMF available in 2013
Simvastatin	Now	Ph.Eur, USP and CP	DMF 26843
Irbesartan	Now	Ph.Eur, USP and CP	CEP 2012-027 DMF 26802
Moxifloxacin	Now	Ph.Eur and USP	DMF available in 2013
Metoprolol succinate	Now	Ph.Eur and USP	DMF available in 2013
Fingolimod	Now	In-house standard	DMF available in 2013
Rosuvastatin calcium	Now	In-house standard	DMF available in 2013
Pitavastatin calcium	Now	In-house standard	DMF available in 2013
Clopidogrel	Now	Ph.Eur and USP	DMF available in 2013
Azilsartan medoxomil	Now	In-house standard	DMF available in 2013
Erlotinib	2013	In-house standard	DMF available in 2013
Olmesartan medoxomil	2013	Ph.Eur and USP	DMF available in 2013
Candesartan cilexetil	2013	Ph.Eur, USP and CP	DMF available in 2013
Entecavir	2013	In-house standard	DMF available in 2013
Escitalopram	2013	USP	DMF available in 2013
Pregabalin	2013	In-house standard	Pending
Imatinib	2013	In-house standard	Pending
Tigecycline	2013	In-house standard	Pending
Aripiprazole	2013	National standard	Pending
Telaprevir	2013	In-house standard	Pending
Ticagrelor	2013	In-house standard	Pending
Apixaban	2013	In-house standard	Pending
Rivaroxaban	2013	In-house standard	Pending
Duloxedine	2013	Ph.Eur	Pending
Dexlansoprazole	2013	In-house sandard	Pending
Pantoprazole	2013	Ph.Eur, USP and CP	Pending
Quetiapine	2013	Ph.Eur, USP and CP	Pending
Sitagliptin	2013	In-house standard	Pending

外销比重：
内销比重：
主要客户：

其它信息
合同定制：
付款条款：

公司详情

HEC Pharm Group is an emerging pharmaceutical company specialized in development, production and marketing of quality and affordable generics, APIs and intermediates for worldwide markets. HEC also provides services for contract R&D and manufacturing.

All manufacture facilities of HEC have been GMP certified by both U.S FDA and European authorities. HEC can provide the value added formulations based on its strong R&D capability. HEC has Zidovudine tablets approved by U.S FDA and Azithromycin tablets approved by German BfArM and WHO.

The company also offers qualified APIs with DMF and CEP, such as Telaprevir, Atorvastatin, Ticagrelor, Clopidogrel, Azilsartan, etc.

联系我们